Literature DB >> 9249603

Podocyte alpha-actinin induction precedes foot process effacement in experimental nephrotic syndrome.

W E Smoyer1, P Mundel, A Gupta, M J Welsh.   

Abstract

Attachment of podocytes to the glomerular basement membrane is thought to be mediated primarily by alpha 3/beta 1-integrins and by cytoskeletal proteins including actin, talin, vinculin, and alpha-actinin. We analyzed the expression of those molecules in rat glomeruli at several time points during induction of podocyte foot process effacement and nephrotic syndrome with puromycin aminonucleoside (PAN). PAN injection resulted in marked induction of glomerular alpha-actinin (40% increase vs. paired controls, P < 0.01), which clearly preceded development of podocyte foot process effacement and proteinuria and localized almost exclusively to podocytes. Delayed induction of glomerular alpha 3-integrin (44% increase vs. paired controls, P < 0.01) following foot process effacement was also observed but was not restricted to podocytes. No significant changes in glomerular vinculin, talin, beta 1-integrin, or total actin expression occurred at any time point during disease development. We conclude that foot process effacement is preceded by induction of alpha-actinin in podocytes in experimental nephrotic syndrome. Altered expression of this actin cross-linking protein in podocytes may have a pathogenic role in foot process effacement in nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9249603     DOI: 10.1152/ajprenal.1997.273.1.F150

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  27 in total

Review 1.  Focusing on the glomerular slit diaphragm: podocin enters the picture.

Authors:  Jeffrey H Miner
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

Review 2.  Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome.

Authors:  Jun Oh; Jochen Reiser; Peter Mundel
Journal:  Pediatr Nephrol       Date:  2003-12-13       Impact factor: 3.714

3.  Activation of adenosine 2A receptors preserves structure and function of podocytes.

Authors:  Alaa S Awad; Michael Rouse; Lixia Liu; Amy L Vergis; Diane L Rosin; Joel Linden; John R Sedor; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2007-11-28       Impact factor: 10.121

4.  TM4SF10 and ADAP interaction in podocytes: role in Fyn activity and nephrin phosphorylation.

Authors:  Timur A Azhibekov; Zhenzhen Wu; Aparna Padiyar; Leslie A Bruggeman; Jeffrey S Simske
Journal:  Am J Physiol Cell Physiol       Date:  2011-08-31       Impact factor: 4.249

5.  Na+/H+ exchanger-1 reduces podocyte injury caused by endoplasmic reticulum stress via autophagy activation.

Authors:  Zhe Feng; Li Tang; Lingling Wu; Shaoyuan Cui; Quan Hong; Guangyan Cai; Di Wu; Bo Fu; Ribao Wei; Xiangmei Chen
Journal:  Lab Invest       Date:  2014-02-24       Impact factor: 5.662

6.  Up-regulation of connexin43 in glomerular podocytes in response to injury.

Authors:  Eishin Yaoita; Jian Yao; Yutaka Yoshida; Tetsuo Morioka; Masaaki Nameta; Takuma Takata; Jun-ichi Kamiie; Hidehiko Fujinaka; Takashi Oite; Tadashi Yamamoto
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 7.  Cell-matrix adhesion of podocytes in physiology and disease.

Authors:  Norman Sachs; Arnoud Sonnenberg
Journal:  Nat Rev Nephrol       Date:  2013-01-22       Impact factor: 28.314

Review 8.  Genetics of idiopathic nephrotic syndrome.

Authors:  Abhay N Vats
Journal:  Indian J Pediatr       Date:  2005-09       Impact factor: 1.967

9.  Immunohistochemical and electronmicroscopic features of mesenchymal-to-epithelial transition in human developing, postnatal and nephrotic podocytes.

Authors:  Natalija Filipovic; Katarina Vukojevic; Ivana Bocina; Marijan Saraga; Merica Glavina Durdov; Boris Kablar; Mirna Saraga-Babic
Journal:  Histochem Cell Biol       Date:  2016-10-01       Impact factor: 4.304

Review 10.  Podocyte-actin dynamics in health and disease.

Authors:  Luca Perico; Sara Conti; Ariela Benigni; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.